ag-1296 has been researched along with tretinoin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H | 1 |
| Reiterer, G; Yen, A | 1 |
| Bunaciu, RP; Reiterer, G; Smith, JL; Yen, A | 1 |
3 other study(ies) available for ag-1296 and tretinoin
| Article | Year |
|---|---|
Identifying off-target effects and hidden phenotypes of drugs in human cells.
Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship | 2006 |
Platelet-derived growth factor receptor regulates myeloid and monocytic differentiation of HL-60 cells.
Topics: ADP-ribosyl Cyclase 1; Antigens, CD; Calcium; CD11b Antigen; Cell Adhesion; Cell Adhesion Molecules; Cell Differentiation; Cholecalciferol; GPI-Linked Proteins; HL-60 Cells; Humans; Lipopolysaccharide Receptors; Membrane Glycoproteins; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Monocytes; Myeloid Cells; Phosphorylation; Receptors, Fc; Receptors, Platelet-Derived Growth Factor; Resting Phase, Cell Cycle; Tretinoin; Tyrphostins; Ubiquitin | 2007 |
Inhibiting the platelet derived growth factor receptor increases signs of retinoic acid syndrome in myeloid differentiated HL-60 cells.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; CD18 Antigens; Cell Differentiation; Cell Movement; Contraindications; Drug Resistance, Neoplasm; Endothelial Cells; HL-60 Cells; Humans; Intercellular Adhesion Molecule-1; Interleukin-8; Leukemia, Promyelocytic, Acute; Ligands; Macrophage-1 Antigen; Matrix Metalloproteinase 9; Protein Kinase Inhibitors; Receptor, Platelet-Derived Growth Factor beta; Receptors, Platelet-Derived Growth Factor; Syndrome; Tretinoin; Tumor Necrosis Factor-alpha; Tyrphostins | 2008 |